Skip to main content
Erschienen in: Indian Journal of Gastroenterology 2/2023

11.05.2023 | Editorial

Sedation for endoscopic procedures: Treading a tightrope

verfasst von: Ankita Dhir, Kajal Jain

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Excerpt

Sedation in the non-operating room for endoscopic procedures has been on a progressive path since its inception in the 1980s. The primary goal of sedation during the performance of these procedures is aimed at providing anxiolysis, amnesia, and analgesia, thus enhancing the success rate of the procedure [1]. For diagnostic endoscopic or routine colonoscopic procedures, mild to moderate sedation using benzodiazepine-opioid combination (e.g. midazolam and fentanyl) has been effective [2]. However, for more complex and invasive procedures such as endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), and peroral endoscopic myotomy (POEM), a deeper level of sedation is desirable to ensure a calm, tranquil, and still patient [3]. The Ramsay Sedation Scale is commonly used to assess the level of sedation in these patients and a score of 3 or 4 is desirable for deep sedation [4]. In deep sedation, patients are not easily arousable, but respond to noxious stimuli and maintain essential functions such as cough reflexes, spontaneous breathing, and cardiovascular stability [5]. However, striking a balance between patient comfort and patient safety during deep sedation is a daunting task. …
Literatur
1.
Zurück zum Zitat Radaelli F, Meucci G, Sgroi G, Minoli G, Italian Association of Hospital Gastroenterologists (AIGO). Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators. Am J Gastroenterol. 2008;103:1122–30.CrossRefPubMed Radaelli F, Meucci G, Sgroi G, Minoli G, Italian Association of Hospital Gastroenterologists (AIGO). Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators. Am J Gastroenterol. 2008;103:1122–30.CrossRefPubMed
2.
Zurück zum Zitat Waring JP, Baron TH, Hirota WK, et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc. 2003;58:317–22.CrossRefPubMed Waring JP, Baron TH, Hirota WK, et al. Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy. Gastrointest Endosc. 2003;58:317–22.CrossRefPubMed
3.
Zurück zum Zitat Dumonceau J-M, Riphaus A, Schreiber F, et al. Non-anesthesiologist administration of propofol for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline-Updated June 2015. Endoscopy. 2015;47:1175–89.CrossRefPubMed Dumonceau J-M, Riphaus A, Schreiber F, et al. Non-anesthesiologist administration of propofol for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline-Updated June 2015. Endoscopy. 2015;47:1175–89.CrossRefPubMed
5.
Zurück zum Zitat Gross JB, Bachenberg KL, Benumof JL, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology. 2006;104:1081–93.CrossRefPubMed Gross JB, Bachenberg KL, Benumof JL, et al. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of patients with obstructive sleep apnea. Anesthesiology. 2006;104:1081–93.CrossRefPubMed
6.
Zurück zum Zitat Ladas SD, Satake Y, Mostafa I, Morse J. Sedation practices for gastrointestinal endoscopy in Europe, North America, Asia, Africa and Australia. Digestion. 2010;82:74–6.CrossRefPubMed Ladas SD, Satake Y, Mostafa I, Morse J. Sedation practices for gastrointestinal endoscopy in Europe, North America, Asia, Africa and Australia. Digestion. 2010;82:74–6.CrossRefPubMed
7.
Zurück zum Zitat Igea F, Casellas JA, González-Huix F, et al. Sedation for gastrointestinal endoscopy. Clinical practice guidelines of the Sociedad Española de Endoscopia Digestiva. Rev Esp Enferm Dig. 2014;106:195–211.PubMed Igea F, Casellas JA, González-Huix F, et al. Sedation for gastrointestinal endoscopy. Clinical practice guidelines of the Sociedad Española de Endoscopia Digestiva. Rev Esp Enferm Dig. 2014;106:195–211.PubMed
8.
Zurück zum Zitat Early DS, Lightdale JR, Vargo JJ, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018;87:327–37.CrossRefPubMed Early DS, Lightdale JR, Vargo JJ, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018;87:327–37.CrossRefPubMed
9.
Zurück zum Zitat Horn E, Nesbit SA. Pharmacology and pharmacokinetics of sedatives and analgesics. Gastrointest Endosc Clin N Am. 2004;14:247–68.CrossRefPubMed Horn E, Nesbit SA. Pharmacology and pharmacokinetics of sedatives and analgesics. Gastrointest Endosc Clin N Am. 2004;14:247–68.CrossRefPubMed
10.
11.
Zurück zum Zitat Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013;19:370–80.CrossRefPubMedPubMedCentral Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013;19:370–80.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56:893–913.CrossRefPubMedPubMedCentral Weerink MAS, Struys MMRF, Hannivoort LN, Barends CRM, Absalom AR, Colin P. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56:893–913.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Tryba M. Choices in sedation: the balanced sedation technique. Eur J Anaesthesiol Suppl. 1996;13:8–12 (discussion 22-5).CrossRefPubMed Tryba M. Choices in sedation: the balanced sedation technique. Eur J Anaesthesiol Suppl. 1996;13:8–12 (discussion 22-5).CrossRefPubMed
14.
Zurück zum Zitat Singh J, Pathania J, Bodh V, Sharma R, Kumar RE, Sharma B. Etomidate‑ketamine versus dexmedetomidine‑ketamine for entropy‑guided procedural sedation during endoscopic retrograde cholangiopancreatography procedures: a randomized single blind study. Indian J Gastroenterol. 2023; 42: https://doi.org/10.1007/s12664-022-01326. Singh J, Pathania J, Bodh V, Sharma R, Kumar RE, Sharma B. Etomidate‑ketamine versus dexmedetomidine‑ketamine for entropy‑guided procedural sedation during endoscopic retrograde cholangiopancreatography procedures: a randomized single blind study. Indian J Gastroenterol. 2023; 42: https://​doi.​org/​10.​1007/​s12664-022-01326.
15.
Zurück zum Zitat Singh A, Iyer KV, Maitra S, et al. Ketamine and dexmedetomidine (Keto-dex) or ketamine and propofol (Keto-fol) for procedural sedation during endoscopic retrograde cholangiopancreatography: which is safer? A randomized clinical trial. Indian J Gastroenterol. 2022;41:583–90.CrossRefPubMed Singh A, Iyer KV, Maitra S, et al. Ketamine and dexmedetomidine (Keto-dex) or ketamine and propofol (Keto-fol) for procedural sedation during endoscopic retrograde cholangiopancreatography: which is safer? A randomized clinical trial. Indian J Gastroenterol. 2022;41:583–90.CrossRefPubMed
16.
Zurück zum Zitat Klein AA, Meek T, Allcock E, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2021: guideline from the Association of Anaesthetists. Anaesthesia. 2021;76:1212–23.CrossRefPubMed Klein AA, Meek T, Allcock E, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2021: guideline from the Association of Anaesthetists. Anaesthesia. 2021;76:1212–23.CrossRefPubMed
18.
Zurück zum Zitat Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology. 2007;133:675–701.CrossRefPubMed Cohen LB, Delegge MH, Aisenberg J, et al. AGA Institute review of endoscopic sedation. Gastroenterology. 2007;133:675–701.CrossRefPubMed
19.
Zurück zum Zitat Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Ansett Pain Med (Seoul). 2022;17:1–11.CrossRef Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Ansett Pain Med (Seoul). 2022;17:1–11.CrossRef
Metadaten
Titel
Sedation for endoscopic procedures: Treading a tightrope
verfasst von
Ankita Dhir
Kajal Jain
Publikationsdatum
11.05.2023
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 2/2023
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-023-01375-3

Weitere Artikel der Ausgabe 2/2023

Indian Journal of Gastroenterology 2/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.